Our Pricing

Complete Wegovy Dosing Schedule - All Doses Available

Published on: June 03, 2026

Finding a pharmacy with the complete wegovy dosing schedule uk and all doses in stock can be challenging during ongoing supply constraints. At Cured Pharmacy, we maintain availability across the full Wegovy dose range—from the initial 0.25mg starter dose through to the 2.4mg maintenance dose—ensuring continuity of your weight loss treatment without interruption.

Understanding the Complete Wegovy Dosing Schedule UK

Wegovy (semaglutide) follows a structured dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes. The complete dosing schedule spans five monthly increments, starting at 0.25mg weekly and gradually increasing to the therapeutic maintenance dose of 2.4mg weekly [1].

This gradual titration approach is critical for tolerability. In the STEP 1 trial, participants who followed the complete dose escalation schedule experienced significantly fewer treatment discontinuations due to adverse events compared to those who escalated more rapidly [1]. The schedule allows your digestive system to adapt to semaglutide's effects on gastric emptying and satiety signalling.

Each dose strength serves a specific purpose in your treatment journey. The initial four doses (0.25mg, 0.5mg, 1.0mg, and 1.7mg) are escalation doses, whilst 2.4mg represents the full therapeutic maintenance dose where maximum weight loss effects are typically observed [2]. Patients remain on each dose for exactly four weeks before progressing to the next strength, subject to prescriber approval and individual tolerance.

The Five-Stage Wegovy Dose Escalation Protocol

The complete wegovy dosing schedule uk requires uninterrupted access to all five dose strengths. Supply chain disruptions affecting even a single dose can force treatment delays or discontinuation, potentially compromising your weight loss progress. At Cured Pharmacy, we stock the full dosing range to ensure seamless progression through your treatment plan.

Month-by-Month Dosing Breakdown

Month 1 begins with Wegovy 0.25mg administered once weekly. This introductory dose initiates GLP-1 receptor activation whilst allowing your body to adjust to the medication's appetite-suppressing effects. Most patients experience minimal side effects at this starter dose.

Month 2 progresses to 0.5mg weekly, doubling the initial dose. This is often when patients first notice meaningful appetite reduction and early weight loss, typically 2-3% of baseline body weight. Month 3 increases to 1.0mg weekly, where weight loss accelerates as semaglutide reaches higher plasma concentrations [1].

Month 4 advances to 1.7mg weekly, approaching the therapeutic range. Clinical data shows this dose produces substantial weight reduction in many patients. Month 5 and beyond continues with the maintenance dose of 2.4mg weekly, which delivered an average 14.9% total body weight reduction over 68 weeks in the STEP 1 trial [1][2].

Why All Doses Must Be Available for Optimal Results

Skipping doses or attempting to jump directly to higher strengths significantly increases the risk of gastrointestinal side effects including nausea, vomiting, and diarrhoea. The MHRA-approved titration schedule exists specifically to balance efficacy with tolerability [3].

Clinical experience across thousands of patients demonstrates that those who complete the full dose escalation schedule show higher treatment adherence rates and superior long-term weight loss outcomes. Interruptions to the dosing schedule—whether due to supply issues or side effects—often result in patients needing to restart at lower doses when resuming treatment.

Having guaranteed access to every dose strength eliminates treatment gaps. When your prescriber approves progression to the next dose, you can transition immediately rather than waiting weeks for supply. This continuity is particularly important during the critical first five months when your body is adapting and weight loss momentum is building.

Wegovy Dosing Schedule Compared to Other Weight Loss Treatments

The complete wegovy dosing schedule uk has been specifically validated through the STEP clinical trial programme, which enrolled over 4,500 participants across multiple studies [1][2]. This extensive evidence base gives UK prescribers confidence in the protocol's safety and efficacy when properly followed.

Dose Escalation Across Different Medications

Unlike Saxenda (liraglutide), which requires daily injections with a longer six-week escalation period, Wegovy's once-weekly schedule offers greater convenience with a five-month titration. Saxenda's maximum dose is 3.0mg daily, whilst Wegovy's 2.4mg weekly dose delivers comparable GLP-1 receptor activation with fewer injections.

Other weight loss medications follow different protocols entirely. Orlistat requires no dose escalation but must be taken three times daily with meals, whilst Mysimba (naltrexone/bupropion) uses a two-week escalation to its maintenance dose. Each medication's dosing schedule reflects its unique mechanism and side effect profile.

Managing Side Effects During Dose Escalation

Gastrointestinal side effects are most common during the first few weeks after each dose increase. Nausea typically peaks 2-3 days post-injection and gradually subsides as your body adapts to the higher dose. Eating smaller, more frequent meals and avoiding high-fat foods can significantly reduce symptom severity [3].

If side effects become intolerable at any dose level, your UK prescriber may recommend remaining on your current dose for an additional month before attempting to escalate. This flexibility is built into the treatment protocol, though it extends your time to reach the full therapeutic dose.

Serious side effects requiring immediate medical attention include persistent severe abdominal pain, signs of pancreatitis, or allergic reactions. These occur rarely but necessitate stopping treatment and seeking urgent medical review. Your Cured Pharmacy clinical team provides ongoing support throughout your dosing schedule to address concerns as they arise.

Starting Your Complete Wegovy Dosing Schedule at Cured Pharmacy

We provide clear written guidance on injection technique, dose progression timelines, and what to expect at each stage of your treatment. Follow-up consultations at each dose increase ensure your prescriber monitors your progress, weight loss trajectory, and any side effects before approving escalation to the next strength. This clinical oversight throughout the complete dosing schedule maximises both safety and outcomes, with pricing from £79.00 for your monthly supply—lower than typical market rates and with full upfront transparency before you begin your consultation.

How the Clinical Assessment Works

Your journey begins with a free online consultation taking under three minutes. Our UK-registered prescribers review your medical history, current medications, weight loss goals, and any contraindications to semaglutide therapy. This assessment determines your eligibility for Wegovy and confirms you can safely begin the dosing schedule.

If approved, your prescription is issued electronically and dispensed by our GPhC-registered pharmacy (9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). Your first month's supply—the 0.25mg starter dose—ships in discreet packaging, typically arriving within 2-3 working days.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg solution for injection in pre-filled pen - Summary of Product Characteristics. MHRA. https://products.mhra.gov.uk/ [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.